caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1417108317

Ravi SinghMD

PRACTICENUEROLIFE MEDICAL GROUP INCSee all providers at this practice →
NeurologyWhittier, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Ravi Singh's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Vincent Fortanasce
Psychiatry & Neurology · Arcadia, CA
3595
Unilab Corporation
Clinical Laboratory · West Hills, CA
2674
BALANCE DREAM DIAGNOSTIC INC1420
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Vincent Fortanasce
Psychiatry & Neurology · Arcadia, CA
2048
Unilab Corporation
Clinical Laboratory · West Hills, CA
2054
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
107
Unique beneficiaries
—
Total services
134
Distinct HCPCS
2
Medicare payment
$14K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,670 Neurology providers in CA — bottom quintile (cohort median 581).
PRESCRIBING · PART D · 2024
Total Rx claims
408
Beneficiaries
—
Total drug cost
$46K
Distinct drugs
14
Brand share
17.9%
Top prescribed drugs
Tizanidine Hcl57 claims
Gabapentin50 claims
Nortriptyline Hcl43 claims
Sumatriptan Succinate41 claims
Levetiracetam34 claims
QUALITY · MIPS · 2024
Final MIPS score
85.6
Quality
64.4
Cost
72.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.45%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.